The joint venture, Life Technologies DaAn Diagnostics is expected to contribute to the early diagnosis of oncology, infectious diseases and genetic diseases.
Life Technologies DaAn Diagnostics will develop and commercialize a range of molecular diagnostic assays using Life Technologies’ 3500Dx Capillary Electrophoresis instrument and the Big Dye Cycle Sequencing technologies.
The collaboration will help both the companies to expand the use of Capillary Electrophoresis technology into the Chinese clinical diagnostics market.
Financial details of the agreement have not been disclosed.